Distribuzione geografica
Continente #
EU - Europa 41590
Totale 41590
Nazione #
IT - Italia 41590
Totale 41590
Città #
Genova 36573
Rapallo 4191
Genoa 826
Totale 41590
Nome #
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population 204
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 172
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. 163
Update on cardiotoxicity of anti-cancer treatments 159
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes. 158
Autophagy in blood cancers: biological role and therapeutic implications. 158
The vulnerable coronary plaque: update on imaging technologies. 157
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 157
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 157
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability. 156
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. 155
Update on the role of cannabinoid receptors after ischemic stroke. 154
Alamandine abrogates neutrophil degranulation in atherosclerotic mice 149
Reply to "Management of left ventricular thrombosis in patients with apical aneurysm". 148
Immune complexes induce monocyte survival through defined intracellular pathways 147
Reactive oxygen-induced cardiac intracellular pathways during ischemia and reperfusion. 147
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 145
Pathophysiology and treatments of oxidative injury in ischemic stroke: Focus on the phagocytic NADPH Oxidase 2 145
Nephrotic syndrome in a patient with IgM myeloma with associated neutrophilia. 144
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. 144
Insulin primes human neutrophils for CCL3-induced migration: crucial role for JNK 1/2. 144
An Oral Formulation of Angiotensin-(1-7) Reverses Corpus Cavernosum Damages Induced by Hypercholesterolemia. 144
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology. 143
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 143
A9.11 Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: a role in atherothrombosis. 142
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 141
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk. 140
Atherosclerosis is an inflammatory disease. 140
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice. 140
Mutation Analysis of PRKAR1A Gene in a Patient with Atrial Myxoma 140
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. 140
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. 139
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 139
Statins and stent thrombosis. 138
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. 138
Pathophysiological role of neutrophils in acute myocardial infarction. 138
Anemia Due to Inflammation in an Anti-Coagulated Patient with Blue Rubber Bleb Nevus Syndrome 138
Treatment with apixaban in a patient with recent chronic subdural haematoma: a case report. 138
Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity. 138
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 137
The role of adipocytokines in atherogenesis and atheroprogression. 137
Potential pathophysiological role for the vitamin D deficiency in essential hypertension. 136
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 135
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. 134
Induction of neutrophil chemotaxis by leptin - Crucial role for p38 and Src kinases. 134
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 134
Cannabinoid receptors in acute and chronic complications of atherosclerosis. 133
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. 133
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 133
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 133
Role of matrix metalloproteinases in animal models of ischemic stroke. 133
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 133
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. 132
Angiotensin II receptor antagonists in acute coronary syndromes. 132
Apelin-13 treatment enhances the stability of atherosclerotic plaques 132
Elevated E-selectin and diastolic blood pressure in diabetic children. 129
Update on the treatments of non-alcoholic fatty liver disease (NAFLD). 129
Dexamethasone-induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95-and XIAP-dependent pathways. 129
Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/I kappaB kinase/nuclear factor kappaB pathway. 128
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. 128
Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk? 128
Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinoma. 128
Update on the role of Angiotensin in the pathophysiology of coronary atherothrombosis. 128
Evidence on the protective role of high-density lipoprotein (HDL) in HIV-infected individuals. 128
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability? 128
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 128
Coronary stenting: A matter of revascularization 128
Update on statin-mediated anti-inflammatory activities in atherosclerosis. 128
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 128
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 128
Anti-apolipoprotein a-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. 127
The Role of the Intraplaque Vitamin D System in Atherogenesis. 127
Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury. 127
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 127
Statins in the treatment of acute ischemic stroke. 127
The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? 127
Impact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and Functions. 127
Sofosbuvir/velpatasvir: A promising combination 126
Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche. 126
Prognostic value of PCSK9 levels in patients with acute coronary syndromes 126
Inflammation in the pathophysiology of essential hypertension. 125
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. 125
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium. 125
Immunological aspects of atherosclerosis. 125
Pathophysiological role of the renin-angiotensin system on erectile dysfunction. 125
New evidence for nicotinic acid treatment to reduce atherosclerosis. 124
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. 124
Serum Resistin and Inflammatory and Endothelial Activation Markers in Obese Adolescents. 124
Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. 123
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 123
Role of Neutrophils in Atherogenesis: an Update 123
Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite 123
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 123
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 123
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. 123
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. 122
Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. 122
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 122
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 122
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. 121
Totale 13580
Categoria #
all - tutte 78161
article - articoli 76137
book - libri 0
conference - conferenze 263
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1761
Totale 156322

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201813 0000 00 00 00013
2018/20193091 101382026 19134 4028 4750410651060
2019/202016653 5843194381966 15661986 27971510 162120711225570
2020/20215649 333613443760 375321 203699 349717262574
2021/20225940 255459305490 348472 3641289 395543280740
2022/20235033 56328056445 656826 7781 906264870
Totale 43322